Range Low Price High Price Comment
30 days $11.32 $14.02 Wednesday, 27th Mar 2024 FOLD stock ended at $11.86. This is 3.76% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 4.81% from a day low at $11.33 to a day high of $11.87.
90 days $11.32 $14.57
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
2024-02-21 $13.53 $13.71 $13.39 $13.56 1 538 849
2024-02-20 $13.60 $13.84 $13.50 $13.70 2 411 631
2024-02-16 $13.89 $13.94 $13.63 $13.76 3 486 136
2024-02-15 $13.30 $14.03 $13.29 $14.00 2 695 383
2024-02-14 $12.91 $13.31 $12.78 $13.18 2 171 281
2024-02-13 $13.26 $13.28 $12.70 $12.80 3 685 316
2024-02-12 $13.60 $13.78 $13.38 $13.77 1 960 903
2024-02-09 $13.48 $13.60 $13.36 $13.55 2 395 967
2024-02-08 $13.11 $13.35 $12.99 $13.33 1 599 679
2024-02-07 $12.97 $13.03 $12.66 $13.00 2 850 239
2024-02-06 $12.61 $13.00 $12.48 $12.98 1 932 317
2024-02-05 $12.25 $12.75 $12.20 $12.70 2 082 242
2024-02-02 $12.43 $12.51 $11.99 $12.44 2 339 571
2024-02-01 $12.52 $12.75 $12.44 $12.67 1 697 272
2024-01-31 $12.68 $12.92 $12.41 $12.43 1 860 206
2024-01-30 $12.90 $12.90 $12.41 $12.65 1 855 776
2024-01-29 $12.33 $13.00 $12.15 $12.97 2 315 190
2024-01-26 $12.75 $12.86 $12.34 $12.34 1 505 789
2024-01-25 $12.73 $12.82 $12.50 $12.64 1 572 702
2024-01-24 $12.57 $12.70 $12.48 $12.57 1 994 795
2024-01-23 $12.59 $12.71 $12.29 $12.46 1 588 567
2024-01-22 $12.19 $12.57 $12.13 $12.43 2 407 944
2024-01-19 $12.44 $12.44 $11.97 $12.03 2 515 541
2024-01-18 $12.83 $12.87 $12.38 $12.42 2 251 962
2024-01-17 $12.65 $12.90 $12.49 $12.84 2 769 162
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT